COMPASS Pathways plc (FRA:5Y6)
Germany · Delayed Price · Currency is EUR 10.10
0.00 (0.00%)
Last updated: Jul 21, 2026, 9:55 AM CET
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of €1.38 billion as of July 21, 2026. Its market cap has increased by 338.25% in one year.
Market Cap
1.38B
Enterprise Value
1.02B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€10.10
ChartMarket Cap Chart
Since September 18, 2020, COMPASS Pathways's market cap has increased from 449.43M to 1.38B, an increase of 207.13%. That is a compound annual growth rate of 21.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 1.46B | 158.12% |
| Dec 31, 2025 | 564.27M | 125.88% |
| Dec 31, 2024 | 249.81M | -49.02% |
| Dec 29, 2023 | 489.98M | 53.16% |
| Dec 30, 2022 | 319.91M | -60.55% |
| Dec 31, 2021 | 810.94M | -42.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 78.00M |
| 2invest AG | 45.07M |
| Biomark Diagnostics | 33.44M |
| Vidac Pharma Holding | 24.01M |
| co.don AG | 427.57K |
| Paion AG | 392.35K |
| bioXXmed AG | 225.65K |